Nautilus Biotechnology, Inc.Nautilus Biotechnology, Inc.Nautilus Biotechnology, Inc.

Nautilus Biotechnology, Inc.

No trades

Fundamentals and stats

The company's current financial position

Total assets for Q1 26 are ‪177.78 M‬ USD, 6.98% less than in Q4 25. And total liabilities decreased by 2.27% in Q1 26 to ‪33.36 M‬ USD.

2020
2021
2022
2023
2024
2025
Total assets
Total liabilities
Currency: USD
2020
2021
2022
2023
2024
2025